Abstract:Recent studies have suggested that autophagy plays a pivotal role in regulation of cancer development and progression. High expression of the autophagy-related Beclin 1 protein predicted favorable patient outcome in several tumors. Here, a randomized controlled trial (RCT)-derived 128 nasopharyngeal carcinoma (NPC) patients were subjected to analysis of Beclin 1 expression and survival probability. In this RCT, 61 patients treated with induction chemotherapy plus concurrent chemoradiotherapy were used as a training set to generate a Beclin 1 cutoff score for patient outcome by receiver operating characteristic (ROC) curve analysis. For validation, the ROC-derived cutoff point was subjected to analysis of the association of Beclin 1 expression with patient outcome and clinical characteristics in testing set. The testing set comprised of 67 patients received induction chemotherapy plus radiotherapy. In the testing set and overall patients, our univariate and multivariate analysis showed that higher Beclin 1 expression, defined by the training set ROC analysis-generated cutoff score, predicted poorer overall survival, progression-free survival and distant metastasis-free survival. However, we failed to detect a correlation between Beclin 1 and local failure-free survival. Moreover, a positive relationship between Beclin 1 and HIF-1 alpha expression was found. Importantly, among patients with elevated HIF-1 alpha expression, a subset with lower Beclin 1 expression displayed a significant overall survival advantage than those with higher expression (p = 0.036). Contrary to previous studies, our results demonstrated that high autophagic Beclin 1 expression was an inferior prognostic marker for NPC. HIF-1 alpha-associated Beclin 1 high expression might facilitate NPC cells surviving from chemoradiotherapy, suggesting a novel therapeutic molecular target for NPC.

Autophagic Protein Beclin 1 Serves As an Independent Positive Prognostic Biomarker for Non-Small Cell Lung Cancer.

Expression of Beclin-1 in non-small cell lung cancer and its clinical significance

High Expression of Beclin-1 Predicts Favorable Prognosis for Patients with Colorectal Cancer.

Beclin 1 Deficiency Correlated with Lymph Node Metastasis, Predicts a Distinct Outcome in Intrahepatic and Extrahepatic Cholangiocarcinoma.

Expression of Beclin 1 in Bladder Cancer and Its Clinical Significance

Beclin 1 and P62 Expression in Non-Small Cell Lung Cancer: Relation with Malignant Behaviors and Clinical Outcome.

High expression of Cullin1 indicates poor prognosis for NSCLC patients.

Low expression of Beclin 1, associated with high Bcl-xL, predicts a malignant phenotype and poor prognosis of gastric cancer

Beclin-1 is a Promising Prognostic Biomarker in a Specific Esophageal Squamous Cell Carcinoma Population

Elevated Beclin 1 expression is correlated with HIF-1alpha in predicting poor prognosis of nasopharyngeal carcinoma.

Loss of Beclin1 expression and Nrf2 overexpression are associated with poor survival of patients with non-small cell lung cancer.

The role of Beclin1 in the occurrence and development of lung adenocarcinoma and its effect onprognosis

Beclin 1 Expression Predicts Favorable Clinical Outcome in Patients with Diffuse Large B-Cell Lymphoma Treated with R-Chop

Prognostic Significance of Beclin-1 Expression in Colorectal Cancer: a Meta-Analysis.

Beclin-1 Expression is a Significant Predictor of Survival in Patients with Lymph Node-Positive Gastric Cancer

The Expression Ofbeclin 1is Associated with Favorable Prognosis in Stage IIIB Colon Cancers

Reduced Expression of Liver Kinase B1 and Beclin1 is Associated with the Poor Survival of Patients with Non-Small Cell Lung Cancer

Beclin 1 expression: a predictor of prognosis in patients with extranodal natural killer T-cell lymphoma, nasal type.

Low expression of Beclin 1 and elevated expression of HIF-1α refine distant metastasis risk and predict poor prognosis of ER-positive, HER2-negative breast cancer

Decreased Expression of Beclin 1 Correlates Closely with Bcl-xL Expression and Poor Prognosis of Ovarian Carcinoma

Beclin-1 Expression Serves As an Important Biomarker for Carcinogenesis and Evolution in Lung Adenocarcinoma Presenting As Ground Glass Opacity